Hongyang Wang
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 115
- Hepatocellular Carcinoma Treatment and Prognosis 94
- Liver physiology and pathology 31
-
- MicroRNA in disease regulation 17
- Co-authors
- Lei Chen (45 shared papers)Yexiong Tan (58 shared papers)Mengchao Wu (45 shared papers)Le‐Xing Yu (20 shared papers)Jin Ding (31 shared papers)Jing Fu (18 shared papers)Bo Jian Zheng (13 shared papers)Yanjing Zhu (14 shared papers)
- Journals
- Hepatology (30 papers)Cancer Letters (28 papers)Journal of Hepatology (13 papers)Acta Pharmacologica Sinica (10 papers)Nature Communications (9 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongyang Wang
486 papers receiving 27.6k citations
Hongyang Wang's Hit Papers
Peers
Comparison fields: 5 of 165
- Hepatology 5.2k
- Cancer Research 4.8k
- Oncology 3.8k
- Molecular Biology 8.5k
- Immunology 1.8k
Countries citing papers authored by Hongyang Wang
This map shows the geographic impact of Hongyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Wang more than expected).
Fields of papers citing papers by Hongyang Wang
This network shows the impact of papers produced by Hongyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Wang. The network helps show where Hongyang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongyang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 495 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA Hit paper breakdown → | 2016 | 938 |
| 2 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Hit paper breakdown → | 2018 | 818 |
| 3 | COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas Hit paper breakdown → | 2021 | 654 |
| 4 | 2020 | 629 | |
| 5 | 1997 | 590 | |
| 6 | New knowledge of the mechanisms of sorafenib resistance in liver cancer Hit paper breakdown → | 2017 | 568 |
| 7 | 2009 | 468 | |
| 8 | 2013 | 371 | |
| 9 | 2008 | 336 | |
| 10 | 2012 | 336 | |
| 11 | 2017 | 324 | |
| 12 | 2020 | 308 | |
| 13 | 2010 | 305 | |
| 14 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Hit paper breakdown → | 2020 | 298 |
| 15 | 2011 | 296 | |
| 16 | Comprehensive analysis of spatial architecture in primary liver cancer Hit paper breakdown → | 2021 | 285 |
| 17 | 2014 | 277 | |
| 18 | 2010 | 274 | |
| 19 | 2017 | 269 | |
| 20 | 2016 | 267 |
About Hongyang Wang
Hongyang Wang is a scholar working on Hepatology, Cancer Research, Oncology, Molecular Biology and Sensory Systems, having authored 495 papers that have together received 28k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (94 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Liver physiology and pathology (31 papers), Hepatitis B Virus Studies (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), Hearing, Cochlea, Tinnitus, Genetics (18 papers), MicroRNA in disease regulation (17 papers) and Cancer Cells and Metastasis (16 papers). The work is most often cited by research in Hepatology (5.2k citations), Cancer Research (4.8k citations), Oncology (3.8k citations), Molecular Biology (8.5k citations) and Immunology (1.8k citations). Hongyang Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lei Chen, Yexiong Tan, Mengchao Wu, Le‐Xing Yu, Jin Ding, Jing Fu, Bo Jian Zheng, Yanjing Zhu, Wen K. Yang and Liwei Dong. Their work appears in journals such as Hepatology, Cancer Letters, Journal of Hepatology, Acta Pharmacologica Sinica and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.